Madagascar vs Venezuela: The number of people with susceptibility test result for rifampicin
Madagascar
15.83
in 2021
Venezuela
3.31
in 2021
Madagascar rank
137th
Venezuela rank
140th
The number of people with susceptibility test result for rifampicin over time
- Madagascar
- Venezuela
How they compare
Madagascar currently reports 15.83 against 3.31 in Venezuela, a difference of 12.52.
That makes Madagascar's figure about 4.8 times Venezuela's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Venezuela ahead.
Madagascar ranks 137th and Venezuela ranks 140th of 146 countries.
Across the 2 decades both report, Madagascar averaged higher in 1 and Venezuela in 1.
Head to head by decade
| Decade | Madagascar | Venezuela | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0111 | 5.64 | 5.62 | Venezuela |
| 2020s | 7.93 | 2.56 | 5.36 | Madagascar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Madagascar or Venezuela?
- Madagascar, at 15.83 against 3.31 in Venezuela as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Madagascar and Venezuela?
- 12.52, with Madagascar ahead.
- How many years of comparable data are there for Madagascar and Venezuela?
- 5 years are reported by both, from 2017 to 2021.
- How do Madagascar and Venezuela rank globally for the number of people with susceptibility test result for rifampicin?
- Madagascar ranks 137th and Venezuela ranks 140th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.